Craneware (CRW) Share Price, News & Analysis

Company Overview

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors. It also offers Trisus Decision Support; Trisus Labor Productivity; Trisus Medication Analytic solutions; and Trisus supplies assistant solutions. In addition, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution that helps covered entities expand medication access; Referral Verification System; and Central Pharmacy Distribution, a centralized purchasing application. Further, it offers appeal, professional, and pharmacy professional services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

Key Stats

• Today's Range: 2,220 to 2,300
• 50-Day Range: 2,070 to 2,470
• 52-Week Range: 1,340.71 to 2,509.20
• Volume: 62,935 shs
• Average Volume: 82,513 shs
• Market Capitalization: £812.36 million
• P/E Ratio: 9,200.00
• Dividend Yield: 1.26%
• Price Target: GBX 2,700
• Consensus Rating: Buy

CRW Stock Analysis - Frequently Asked Questions

How have CRW shares performed this year?

Craneware's stock was trading at GBX 1,750 at the beginning of 2024. Since then, CRW shares have increased by 31.4% and is now trading at GBX 2,300.
View the best growth stocks for 2024 here.

How do I buy shares of Craneware?

Shares of CRW stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Craneware own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Craneware investors own include Diageo (DEO), Blue Prism Group (PRSM), accesso Technology Group (ACSO), Boeing (BA), IAMGOLD (IAG), Maxar Technologies (MAXR) and McDonald's (MCD).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: LON:CRW
• CUSIP: N/A
• CIK: N/A
• Web: public.craneware.com
• Phone: +44-131-5503100
• Fax: N/A
• Employees: 734
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: GBX 2,700
• High Stock Price Target: GBX 2,700
• Low Stock Price Target: GBX 2,700
• Potential Upside/Downside: +17.4%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): GBX 0.25
• Trailing P/E Ratio: 9,200.00
• Forward P/E Ratio: 28.48
• P/E Growth: N/A
• Net Income: £11.70 million
• Net Margins: 6.18%
• Pretax Margin: N/A
• Return on Equity: 3.57%
• Return on Assets: 2.28%

Debt

• Debt-to-Equity Ratio: 12.22
• Current Ratio: 0.63
• Quick Ratio: 1.00

Sales & Book Value

• Annual Sales: £189.27 million
• Price / Sales: 4.29
• Cash Flow: GBX 156.28 per share
• Price / Cash Flow: 14.72
• Book Value: GBX 940 per share
• Price / Book: 2.45

Miscellaneous

• Outstanding Shares: 35,320,000
• Free Float: N/A
• Market Cap: £812.36 million
• Optionable: Not Optionable
• Beta: 0.28